2019
DOI: 10.1080/17474086.2019.1634542
|View full text |Cite
|
Sign up to set email alerts
|

Bariatric venous thromboembolism prophylaxis: an update on the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 62 publications
0
11
0
Order By: Relevance
“…For example, anticoagulation treatment alone may not alter immune response to inflammation in VTE and PE [29]. Moreover, findings from studies included in this review may be more applicable to clinical settings within developed countries due to differences in environmental factors, prophylaxis and medical interventions such as biomarkers risk stratification [30]. It might be helpful for future studies to explore the relationship between inflammatory mediators such as C-reactive protein (CRP), tumor necrosis factor-alpha, IL-6, and IL-8, and risk of VTE or PE.…”
Section: Clinical Significancementioning
confidence: 99%
“…For example, anticoagulation treatment alone may not alter immune response to inflammation in VTE and PE [29]. Moreover, findings from studies included in this review may be more applicable to clinical settings within developed countries due to differences in environmental factors, prophylaxis and medical interventions such as biomarkers risk stratification [30]. It might be helpful for future studies to explore the relationship between inflammatory mediators such as C-reactive protein (CRP), tumor necrosis factor-alpha, IL-6, and IL-8, and risk of VTE or PE.…”
Section: Clinical Significancementioning
confidence: 99%
“…Fourth, in terms of prophylaxis against VTE and its effectiveness, while some research suggests that there appears to be not enough data to recommend the most effective and safe prophylaxis [ 128 ], recent work has provided updates for clinical practice guidelines for thromboembolic prophylaxis in bariatric patients [ 138 ], as well as other useful information of perioperative complications in morbid obesity [ 58 , 139 ].…”
Section: Resultsmentioning
confidence: 99%
“…Nearly half of the respondents commence LMWH prophylaxis on the day of surgery for the patients undergoing BMS but a minority did not recommend any. A review of the literature showed that LMWHs might be better options than unfractionated heparin (UFH) for venous thromboembolism (VTE) prophylaxis in bariatric patients, but further research and consensus are needed for the best thromboprophylaxis modality, dose, and duration (37)(38)(39).…”
Section: Lmwh Prophylaxismentioning
confidence: 99%